首页> 美国卫生研究院文献>BMC Veterinary Research >A gDgC-substituted pseudorabies virus vaccine strain provides complete clinical protection and is helpful to prevent virus shedding against challenge by a Chinese pseudorabies variant
【2h】

A gDgC-substituted pseudorabies virus vaccine strain provides complete clinical protection and is helpful to prevent virus shedding against challenge by a Chinese pseudorabies variant

机译:用gD&gC取代的伪狂犬病病毒疫苗株可提供完整的临床保护并有助于防止病毒脱落免受中国伪狂犬病变种的攻击

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundSince 2011, pseudorabies caused by a variant PRV has re-emerged in many Chinese Bartha-K61-vaccinated pig farms. An efficacious vaccine is necessary to control this disease. We described the construction of a gD&gC-substituted pseudorabies virus (PRV B-gD&gCS) from the Bartha-K61 (as backbone) and AH02LA strain (as template for gD and gC genes) through bacterial artificial chromosome (BAC) technology using homologous recombination. The growth kinetics of PRV B-gD&gCS was compared with Bartha-K61. Its safety was evaluated in 28-day-old piglets. Protection efficacy was tested in piglets by lethal challenge with AH02LA at 7 days post vaccination, including body temperature, clinical symptoms, virus shedding, mortality rate, and lung lesions.
机译:背景自2011年以来,许多中国Bartha-K61疫苗接种猪场再次出现了由PRV变异引起的伪狂犬病。有效的疫苗是控制这种疾病所必需的。我们描述了通过细菌人工染色体从Bartha-K61(作为骨架)和AH02LA菌株(作为gD和gC基因的模板)构建gD&gC取代的伪狂犬病病毒(PRV B-gD&gC S )的方法(BAC)技术使用同源重组。将PRV B-gD&gC S 与Bartha-K61的生长动力学进行了比较。在28日龄的仔猪中评估了其安全性。接种疫苗后7天,用AH02LA致死性攻击,测试了仔猪的保护效果,包括体温,临床症状,病毒脱落,死亡率和肺部病变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号